Results 21 to 30 of about 117,965 (261)

Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice

Рациональная фармакотерапия в кардиологии, 2020
Aim. To study the frequency of prescribing anticoagulant therapy in outpatients with AF in accordance with clinical guidelines.Material and methods. Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF) observational study was conducted at ...
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko   +2 more
doaj   +1 more source

Perioperative management of anticoagulant therapy

Innovative Surgical Sciences, 2019
About 10% of patients taking a chronic, oral anticoagulant therapy require an invasive procedure that can be associated with an increased risk for peri-interventional or perioperative bleeding.
Wagner Johanna, Lock Johan F., Kastner Carolin, Klein Ingo, Krajinovic Katica, Löb Stefan, Germer Christoph-Thomas, Wiegering Armin   +7 more
doaj   +1 more source

PATTERN OF ANTICOAGULANT THERAPY IN CARDIOEMBOLIC STROKE

Malang Neurology Journal, 2023
Background: Cardioembolic stroke is a category of ischemic stroke that manifests more severe, is prone to recurrence, and is related to a higher mortality rate than the other categories of ischemic stroke.
Reihan Achmad Reza, Lisda Amalia, Nushrotul Lailiyya Dahlan, Cep Juli, Hanna Goenawan   +4 more
doaj   +1 more source

Management and Anticoagulation Treatment of Non-Valvular Atrial Fibrillation in Elderly Patients: The Dali Study

International Journal of General Medicine, 2023
Hong Huang, Nai-Qing Hu, Jun-Yun Yang, Yu-Luan Xiang, Yuan-Zhao Zhu, Qian-Ru Du, Xue-Yan Yin, Jin-lin Lv, Li-Hua Li Department of Gerontology, The First Affiliated Hospital of Dali University, Dali, Yunnan Province, 671000, People’s Republic of ...
Huang H, Hu NQ, Yang JY, Xiang YL, Zhu YZ, Du QR, Yin XY, Lv JL, Li LH   +8 more
doaj  

Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study

BMC Cardiovascular Disorders, 2020
Background It has been reported that oral anticoagulation (OAC) is underused among Chinese patients with non-valvular atrial fibrillation (NVAF). Non-vitamin K antagonist oral anticoagulants (NOAC) have been recommended by recent guidelines and have been
Ting Liu, Hui-li Yang, Lan Gu, Jie Hui, Ojo Omorogieva, Meng-xiao Ren, Xiao-hua Wang   +6 more
doaj   +1 more source

Bleeding in a COVID-19 Patient; Rectus Hematoma

Northwestern Medical Journal, 2021
Anticoagulant therapy is part of the treatment of hospitalized COVID-19 patients. Low molecular weight heparin or oral anticoagulant drugs are used in its treatment. However this approach may increase the risks of bleeding.
Kader Zeybek Aydoğan, Selman Alkan, Elif Ayşe Uçar   +2 more
doaj   +1 more source

Trend of anticoagulant therapy in elderly patients with atrial fibrillation considering risks of cerebral infarction and bleeding

Scientific Reports, 2023
The introduction of direct oral anticoagulants (DOACs) has greatly changed the use of anticoagulant therapy in patients with non-valvular atrial fibrillation (Af).
Noriko Tsuji, Yoshimitsu Takahashi, Michi Sakai, Shosuke Ohtera, Junji Kaneyama, Kosai Cho, Genta Kato, Shigeru Ohtsuru, Takeo Nakayama   +8 more
doaj   +1 more source

A Guide to Anticoagulant Therapy [PDF]

Circulation, 1961
The physician who undertakes anticoagulant therapy tampers with one of the most important homeostatic functions of the body. In so doing, he subjects the patient to the calculated hazard of possible hemorrhage balanced against the risks of the thrombosis or embolism that he seeks to prevent or treat.
B, ALEXANDER, S, WESSLER
openaire   +2 more sources

Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Literature review

Российский кардиологический журнал, 2023
The review article discusses the issues of anticoagulant therapy in cardiovascular patients with thrombocytopenia (TP), gives the concept of ethylenediaminetetraacetic acidand heparin-induced TP.
K. G. Pereverzeva, S. S. Yakushin, A. An. Korshikova   +2 more
doaj   +1 more source

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage

Рациональная фармакотерапия в кардиологии, 2021
Intracerebral hemorrhage (ICH) is severe and fatal complication of anticoagulant therapy with an incidence 0.3-0.7% per year. For patients with atrial fibrillation (AF) anticoagulants are administered for decreasing risk of stroke and systemic embolism ...
A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov   +3 more
doaj   +1 more source